These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 2411402)
1. Therapy for chronic myelogenous leukemia in blast crisis with etoposide and 5-azacitidine administered by continuous infusion: a Cancer and Leukemia group B Study. Schiffer CA; Anderson K; Coleman M; Cuttner J Cancer Treat Rep; 1985 Sep; 69(9):1027-8. PubMed ID: 2411402 [No Abstract] [Full Text] [Related]
2. Intensive chemotherapy with mitoxantrone administered as a single injection in patients with high-risk acute myeloid leukemia: results of the EMA 2000 trial. Thomas X; Elhamri M; Chelghoum Y; Reman O; Arnaud P; Raffoux E; Le QH; Tavernier E; Dombret H; Michallet M Ann Hematol; 2005 Jun; 84(6):376-82. PubMed ID: 15782343 [TBL] [Abstract][Full Text] [Related]
3. P-glycoprotein (Pgp) modulation in untreated acute myeloid leukemia (AML): Cancer and Leukemia Group B (CALGB) trials in younger and older adults. Kolitz JE; George SL; Baer MR; Lee EJ; Bloomfield CD; Larson RA; Ann Hematol; 2004; 83 Suppl 1():S103-4. PubMed ID: 15124695 [No Abstract] [Full Text] [Related]
4. Treatment of the blast crisis of chronic myelogenous leukemia with 5-azacitidine and VP-16-213. Schiffer CA; DeBellis R; Kasdorf H; Wiernik PH Cancer Treat Rep; 1982 Feb; 66(2):267-71. PubMed ID: 6173123 [TBL] [Abstract][Full Text] [Related]
5. Imatinib combined with mitoxantrone/etoposide and cytarabine is an effective induction therapy for patients with chronic myeloid leukemia in myeloid blast crisis. Fruehauf S; Topaly J; Buss EC; Fischer T; Ottmann OG; Emmerich B; Müller MC; Schuld P; Balleisen L; Hehlmann R; Ho AD; Hochhaus A Cancer; 2007 Apr; 109(8):1543-9. PubMed ID: 17340589 [TBL] [Abstract][Full Text] [Related]
6. Intensive short-term chemotherapy for patients with acute myelogenous leukemia: long-term follow-up. Oblon DJ; Weiner RS; Kramer BS; Ross W; Noyes WD; Boyett J; Kitchens CS Cancer Treat Rep; 1985 Dec; 69(12):1425-7. PubMed ID: 2416439 [TBL] [Abstract][Full Text] [Related]
8. Amsacrine alone or in combination with 5-azacytidine and etoposide in refractory or relapsed acute non lymphoblastic leukemia (ANLL). Carella AM; Santini G; Martinengo M; Nati S; Giordano D; Congiu A; Cerri R; Damasio E; Risso M; Rossi E Haematologica; 1985; 70(1):39-43. PubMed ID: 2408974 [No Abstract] [Full Text] [Related]
9. [Blast crisis in chronic myeloid leukemia]. Fink R; Höche D; Wutke K Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(4):517-25. PubMed ID: 6196268 [TBL] [Abstract][Full Text] [Related]
10. Treatment of acute leukemia with idarubicin, etoposide and cytarabine (IDEA). A randomized study of etoposide schedule. Damon LE; Johnston LJ; Ries CA; Rugo HS; Case D; Ault K; Linker CA Cancer Chemother Pharmacol; 2004 Jun; 53(6):468-74. PubMed ID: 15138711 [TBL] [Abstract][Full Text] [Related]
11. Vindesine-prednisone in the treatment of blast crisis of chronic myeloid leukemia. Lemoine F; Najman A; Laporte JP; Gorin NC; Duhamel G Cancer Treat Rep; 1985 Feb; 69(2):203-4. PubMed ID: 3855698 [TBL] [Abstract][Full Text] [Related]
12. [A case of chronic myelocytic leukemia with B-lymphoid crisis responding to the VP therapy followed by lymphoid-myeloid crisis]. Tomiyama J; Kamiyama T; Momoi M; Kudou H; Adachi Y; Kinugasa K; Takase K; Ookawa Y Rinsho Ketsueki; 1987 Mar; 28(3):434-40. PubMed ID: 3475488 [No Abstract] [Full Text] [Related]
13. Combination therapy with mitoxantrone and etoposide in refractory acute myelogenous leukemia. Ho AD; Lipp T; Ehninger G; Meyer P; Freund M; Hunstein W Cancer Treat Rep; 1986 Aug; 70(8):1025-7. PubMed ID: 3460698 [TBL] [Abstract][Full Text] [Related]
14. Mitoxantrone, etoposide, and cytarabine plus cyclosporine for patients with relapsed or refractory acute myeloid leukemia: an Eastern Cooperative Oncology Group pilot study. Tallman MS; Lee S; Sikic BI; Paietta E; Wiernik PH; Bennett JM; Rowe JM Cancer; 1999 Jan; 85(2):358-67. PubMed ID: 10023703 [TBL] [Abstract][Full Text] [Related]
15. Time sequential chemotherapy for primary refractory or relapsed adult acute myeloid leukemia: results of the phase II Gemia protocol. Martino R; Guardia R; Altés A; Sureda A; Brunet S; Sierra J Haematologica; 1999 Mar; 84(3):226-30. PubMed ID: 10189387 [TBL] [Abstract][Full Text] [Related]